35 related articles for article (PubMed ID: 8106784)
1. Molecular Analysis of Dihydropteroate Synthase Gene Mutations in
Tsvetkova N; Harizanov R; Rainova I; Ivanova A; Yancheva-Petrova N
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069248
[No Abstract] [Full Text] [Related]
2.
Ibrahim A; Chattaraj A; Iqbal Q; Anjum A; Rehman MEU; Aijaz Z; Nasir F; Ansar S; Zangeneh TT; Iftikhar A
Avicenna J Med; 2023 Jan; 13(1):23-34. PubMed ID: 36969352
[No Abstract] [Full Text] [Related]
3.
Takeuchi K; Yakushijin Y
Pathogens; 2021 Feb; 10(2):. PubMed ID: 33669742
[No Abstract] [Full Text] [Related]
4. Combined computational and experimental studies on cysteine-sulfadiazine adduct formation.
Acar SelÇukİ N; CoŞkun E; BİÇer E
Turk J Chem; 2020; 44(2):502-517. PubMed ID: 33488173
[TBL] [Abstract][Full Text] [Related]
5. Multitarget Approaches against Multiresistant Superbugs.
Gray DA; Wenzel M
ACS Infect Dis; 2020 Jun; 6(6):1346-1365. PubMed ID: 32156116
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.
Minato Y; Thiede JM; Kordus SL; McKlveen EJ; Turman BJ; Baughn AD
Antimicrob Agents Chemother; 2015 Sep; 59(9):5097-106. PubMed ID: 26033719
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of drug combinations: interaction and network perspectives.
Jia J; Zhu F; Ma X; Cao Z; Cao ZW; Li Y; Li YX; Chen YZ
Nat Rev Drug Discov; 2009 Feb; 8(2):111-28. PubMed ID: 19180105
[TBL] [Abstract][Full Text] [Related]
8. Prevention of infection due to Pneumocystis carinii.
Fishman JA
Antimicrob Agents Chemother; 1998 May; 42(5):995-1004. PubMed ID: 9593116
[No Abstract] [Full Text] [Related]
9. Enhanced in vitro activity of WR99210 in combination with dapsone against Mycobacterium avium complex.
Shah LM; DeStefano MS; Cynamon MH
Antimicrob Agents Chemother; 1996 Nov; 40(11):2644-5. PubMed ID: 8913480
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
Hong YL; Hossler PA; Calhoun DH; Meshnick SR
Antimicrob Agents Chemother; 1995 Aug; 39(8):1756-63. PubMed ID: 7486915
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients.
Armstrong W; Meshnick S; Kazanjian P
Microbes Infect; 2000 Jan; 2(1):61-7. PubMed ID: 10717542
[TBL] [Abstract][Full Text] [Related]
12. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.
Huang L; Crothers K; Atzori C; Benfield T; Miller R; Rabodonirina M; Helweg-Larsen J
Emerg Infect Dis; 2004 Oct; 10(10):1721-8. PubMed ID: 15504256
[TBL] [Abstract][Full Text] [Related]
13. Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone).
Voeller D; Kovacs J; Andrawis V; Chu E; Masur H; Allegra C
J Infect Dis; 1994 Feb; 169(2):456-9. PubMed ID: 8106784
[TBL] [Abstract][Full Text] [Related]
14. Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium.
Chio LC; Bolyard LA; Nasr M; Queener SF
Antimicrob Agents Chemother; 1996 Mar; 40(3):727-33. PubMed ID: 8851601
[TBL] [Abstract][Full Text] [Related]
15. Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.
Allegra CJ; Boarman D; Kovacs JA; Morrison P; Beaver J; Chabner BA; Masur H
J Clin Invest; 1990 Feb; 85(2):371-9. PubMed ID: 2298911
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
